LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 61.56 | 27.76 | 1031 | 6217 | 0.1658 | 0.5888 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 61.56 | 27.76 | 1046 | 6217 | 0.1682 | 0.5918 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 61.56 | 27.76 | 197 | 6217 | 0.0317 | 0.2853 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 61.56 | 27.76 | 1507 | 6217 | 0.2424 | 0.6680 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 63.26 | 27.76 | 1035 | 6465 | 0.1601 | 0.5843 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 63.26 | 27.76 | 1052 | 6465 | 0.1627 | 0.5876 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 63.26 | 27.76 | 244 | 6465 | 0.0377 | 0.3184 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 63.26 | 27.76 | 1570 | 6465 | 0.2428 | 0.6706 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 64.97 | 27.76 | 1040 | 6656 | 0.1562 | 0.5814 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 64.97 | 27.76 | 1054 | 6656 | 0.1583 | 0.5841 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 64.97 | 27.76 | 223 | 6656 | 0.0335 | 0.3016 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 64.97 | 27.76 | 1527 | 6656 | 0.2294 | 0.6602 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 66.67 | 27.76 | 1074 | 6695 | 0.1604 | 0.5871 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 66.67 | 27.76 | 1088 | 6695 | 0.1625 | 0.5897 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 66.67 | 27.76 | 233 | 6695 | 0.0348 | 0.3084 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 66.67 | 27.76 | 1585 | 6695 | 0.2367 | 0.6671 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 68.37 | 27.76 | 1064 | 6879 | 0.1547 | 0.5816 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 68.37 | 27.76 | 1075 | 6879 | 0.1563 | 0.5837 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 68.37 | 27.76 | 243 | 6879 | 0.0353 | 0.3136 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 68.37 | 27.76 | 1588 | 6879 | 0.2308 | 0.6633 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 70.08 | 27.76 | 1075 | 6849 | 0.1569 | 0.5843 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 70.08 | 27.76 | 1088 | 6849 | 0.1588 | 0.5867 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 70.08 | 27.76 | 238 | 6849 | 0.0347 | 0.3105 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 70.08 | 27.76 | 1590 | 6849 | 0.2321 | 0.6642 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 71.78 | 27.76 | 1109 | 6893 | 0.1609 | 0.5896 | MN20160318_Q01 | D07 |